Allan Brown
Vorstandsvorsitzender bei Glycoscoredx Ltd.
Profil
Allan Brown is currently the Chief Executive Officer at Glycoscoredx Ltd.
Prior to this, he worked as an Executive Director & COO-Diagnostics Division at Genedrive Plc from 2015 to 2017.
He also worked as a Divisional Managing Director at Hologic Ltd.
Aktive Positionen von Allan Brown
Unternehmen | Position | Beginn |
---|---|---|
Glycoscoredx Ltd.
Glycoscoredx Ltd. Miscellaneous Commercial ServicesCommercial Services Glycoscoredx Ltd. develops a novel blood test that revolutionizes how prostate cancer is diagnosed. The company is based in Newcastle upon Tyne, UK. The British company was founded in 2020 by Jennifer Munkley. Allan Brown has been the CEO of the company since 2020. | Vorstandsvorsitzender | 01.09.2020 |
Ehemalige bekannte Positionen von Allan Brown
Unternehmen | Position | Ende |
---|---|---|
GENEDRIVE PLC | Geschäftsführer | 08.11.2017 |
Hologic Ltd.
Hologic Ltd. Medical SpecialtiesHealth Technology Hologic Ltd. manufactures life sciences products and services with two divisions, Molecular Diagnostics and Research Products & Services. The firm has laboratories, manufacturing and operations in the USA, UK and France. It provides test kits, reagents and services to two synergistic markets. It focuses on these niche opportunities with products, patents, expertise and acquisitions. The company was founded in 1992 and is headquartered in Wythenshawe, the United Kingdom. | Corporate Officer/Principal | 01.01.2010 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GENEDRIVE PLC | Health Technology |
Private Unternehmen | 2 |
---|---|
Hologic Ltd.
Hologic Ltd. Medical SpecialtiesHealth Technology Hologic Ltd. manufactures life sciences products and services with two divisions, Molecular Diagnostics and Research Products & Services. The firm has laboratories, manufacturing and operations in the USA, UK and France. It provides test kits, reagents and services to two synergistic markets. It focuses on these niche opportunities with products, patents, expertise and acquisitions. The company was founded in 1992 and is headquartered in Wythenshawe, the United Kingdom. | Health Technology |
Glycoscoredx Ltd.
Glycoscoredx Ltd. Miscellaneous Commercial ServicesCommercial Services Glycoscoredx Ltd. develops a novel blood test that revolutionizes how prostate cancer is diagnosed. The company is based in Newcastle upon Tyne, UK. The British company was founded in 2020 by Jennifer Munkley. Allan Brown has been the CEO of the company since 2020. | Commercial Services |